Search

everythinglearnresearchcommunity

for

Search:↓

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

Some gonadal hormone drugs can block filovirus entry into cells.

Cepharanthine shows promise as a COVID-19 treatment.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Indinavir and ritonavir therapy can cause reversible hair loss.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Five FDA-approved drugs may help block COVID-19 virus entry.

A blood pressure drug, diltiazem, may also help treat influenza.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Plant compounds may boost antiviral treatments.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Nilotinib can cause keratosis pilaris, a skin condition.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

New method makes important drug ingredients more easily without needing extra purification steps.

Some HIV treatments can harm mitochondria, potentially causing side effects like lactic acidosis and nerve damage.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.